Global Immune Health Product 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR082417336

Publication Date:

August 29, 2024

Pages:

102

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Immune health products are health products that can improve immunity and promote metabolism.
The global Immune Health Product market size was valued at US$ 53620 million in 2023 and is forecast to a readjusted size of USD 81070 million by 2030 with a CAGR of 6.2% during review period.
Global Immune Health Product key players include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe and China, both have a share over 37 percent. In terms of product, Capsule/Pills is the largest segment, with a share over 81%. And in terms of End User, the largest End User is Adults, followed by Men, etc.
This report is a detailed and comprehensive analysis for global Immune Health Product market. Both quantitative and qualitative analyses are presented by company, by region & country, by Form and by End Users. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Immune Health Product market size and forecasts, in consumption value ($ Million), 2019-2030
Global Immune Health Product market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Immune Health Product market size and forecasts, by Form and by End Users, in consumption value ($ Million), 2019-2030
Global Immune Health Product market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Health Product
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Health Product market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, USANA Health Sciences, Inc., PERFECT, Nestl茅 SA, H&H Group, China New Era Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Immune Health Product market is split by Form and by End Users. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Form and by End Users. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segmentation
Immune Health Product market is split by Form and by End Users. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Form and by End Users. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Form
Capsule/Pills
Powder
Liquid
麻豆原创 segment by End Users
Children/Teenagers
Men
Adults
The Elderly
麻豆原创 segment by players, this report covers
Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestl茅 SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
狈补迟耻谤别鈥檚
Real Nutriceutical
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immune Health Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immune Health Product, with revenue, gross margin, and global market share of Immune Health Product from 2019 to 2024.
Chapter 3, the Immune Health Product competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Form and by End Users, with consumption value and growth rate by Form, by End Users, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immune Health Product market forecast, by regions, by Form and by End Users, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Health Product.
Chapter 13, to describe Immune Health Product research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Immune Health Product by Form
1.3.1 Overview: Global Immune Health Product 麻豆原创 Size by Form: 2019 Versus 2023 Versus 2030
1.3.2 Global Immune Health Product Consumption Value 麻豆原创 Share by Form in 2023
1.3.3 Capsule/Pills
1.3.4 Powder
1.3.5 Liquid
1.4 Global Immune Health Product 麻豆原创 by End Users
1.4.1 Overview: Global Immune Health Product 麻豆原创 Size by End Users: 2019 Versus 2023 Versus 2030
1.4.2 Children/Teenagers
1.4.3 Men
1.4.4 Adults
1.4.5 The Elderly
1.5 Global Immune Health Product 麻豆原创 Size & Forecast
1.6 Global Immune Health Product 麻豆原创 Size and Forecast by Region
1.6.1 Global Immune Health Product 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Immune Health Product 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Immune Health Product 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Immune Health Product 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Immune Health Product 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Immune Health Product 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Immune Health Product 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Amway
2.1.1 Amway Details
2.1.2 Amway Major Business
2.1.3 Amway Immune Health Product Product and Solutions
2.1.4 Amway Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Amway Recent Developments and Future Plans
2.2 Suntory
2.2.1 Suntory Details
2.2.2 Suntory Major Business
2.2.3 Suntory Immune Health Product Product and Solutions
2.2.4 Suntory Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Suntory Recent Developments and Future Plans
2.3 GNC
2.3.1 GNC Details
2.3.2 GNC Major Business
2.3.3 GNC Immune Health Product Product and Solutions
2.3.4 GNC Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 GNC Recent Developments and Future Plans
2.4 INFINITUS
2.4.1 INFINITUS Details
2.4.2 INFINITUS Major Business
2.4.3 INFINITUS Immune Health Product Product and Solutions
2.4.4 INFINITUS Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 INFINITUS Recent Developments and Future Plans
2.5 Herbalife Nutrition
2.5.1 Herbalife Nutrition Details
2.5.2 Herbalife Nutrition Major Business
2.5.3 Herbalife Nutrition Immune Health Product Product and Solutions
2.5.4 Herbalife Nutrition Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Herbalife Nutrition Recent Developments and Future Plans
2.6 USANA Health Sciences, Inc.
2.6.1 USANA Health Sciences, Inc. Details
2.6.2 USANA Health Sciences, Inc. Major Business
2.6.3 USANA Health Sciences, Inc. Immune Health Product Product and Solutions
2.6.4 USANA Health Sciences, Inc. Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 USANA Health Sciences, Inc. Recent Developments and Future Plans
2.7 PERFECT
2.7.1 PERFECT Details
2.7.2 PERFECT Major Business
2.7.3 PERFECT Immune Health Product Product and Solutions
2.7.4 PERFECT Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 PERFECT Recent Developments and Future Plans
2.8 Nestl茅 SA
2.8.1 Nestl茅 SA Details
2.8.2 Nestl茅 SA Major Business
2.8.3 Nestl茅 SA Immune Health Product Product and Solutions
2.8.4 Nestl茅 SA Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Nestl茅 SA Recent Developments and Future Plans
2.9 H&H Group
2.9.1 H&H Group Details
2.9.2 H&H Group Major Business
2.9.3 H&H Group Immune Health Product Product and Solutions
2.9.4 H&H Group Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 H&H Group Recent Developments and Future Plans
2.10 China New Era Group
2.10.1 China New Era Group Details
2.10.2 China New Era Group Major Business
2.10.3 China New Era Group Immune Health Product Product and Solutions
2.10.4 China New Era Group Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 China New Era Group Recent Developments and Future Plans
2.11 By-health
2.11.1 By-health Details
2.11.2 By-health Major Business
2.11.3 By-health Immune Health Product Product and Solutions
2.11.4 By-health Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 By-health Recent Developments and Future Plans
2.12 Black Mores
2.12.1 Black Mores Details
2.12.2 Black Mores Major Business
2.12.3 Black Mores Immune Health Product Product and Solutions
2.12.4 Black Mores Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Black Mores Recent Developments and Future Plans
2.13 Glanbia Plc
2.13.1 Glanbia Plc Details
2.13.2 Glanbia Plc Major Business
2.13.3 Glanbia Plc Immune Health Product Product and Solutions
2.13.4 Glanbia Plc Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Glanbia Plc Recent Developments and Future Plans
2.14 狈补迟耻谤别鈥檚
2.14.1 狈补迟耻谤别鈥檚 Details
2.14.2 狈补迟耻谤别鈥檚 Major Business
2.14.3 狈补迟耻谤别鈥檚 Immune Health Product Product and Solutions
2.14.4 狈补迟耻谤别鈥檚 Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 狈补迟耻谤别鈥檚 Recent Developments and Future Plans
2.15 Real Nutriceutical
2.15.1 Real Nutriceutical Details
2.15.2 Real Nutriceutical Major Business
2.15.3 Real Nutriceutical Immune Health Product Product and Solutions
2.15.4 Real Nutriceutical Immune Health Product Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Real Nutriceutical Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Immune Health Product Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Immune Health Product by Company Revenue
3.2.2 Top 3 Immune Health Product Players 麻豆原创 Share in 2023
3.2.3 Top 6 Immune Health Product Players 麻豆原创 Share in 2023
3.3 Immune Health Product 麻豆原创: Overall Company Footprint Analysis
3.3.1 Immune Health Product 麻豆原创: Region Footprint
3.3.2 Immune Health Product 麻豆原创: Company Product Type Footprint
3.3.3 Immune Health Product 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Form
4.1 Global Immune Health Product Consumption Value and 麻豆原创 Share by Form (2019-2024)
4.2 Global Immune Health Product 麻豆原创 Forecast by Form (2025-2030)
5 麻豆原创 Size Segment by End Users
5.1 Global Immune Health Product Consumption Value 麻豆原创 Share by End Users (2019-2024)
5.2 Global Immune Health Product 麻豆原创 Forecast by End Users (2025-2030)
6 North America
6.1 North America Immune Health Product Consumption Value by Form (2019-2030)
6.2 North America Immune Health Product 麻豆原创 Size by End Users (2019-2030)
6.3 North America Immune Health Product 麻豆原创 Size by Country
6.3.1 North America Immune Health Product Consumption Value by Country (2019-2030)
6.3.2 United States Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Immune Health Product Consumption Value by Form (2019-2030)
7.2 Europe Immune Health Product Consumption Value by End Users (2019-2030)
7.3 Europe Immune Health Product 麻豆原创 Size by Country
7.3.1 Europe Immune Health Product Consumption Value by Country (2019-2030)
7.3.2 Germany Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Immune Health Product Consumption Value by Form (2019-2030)
8.2 Asia-Pacific Immune Health Product Consumption Value by End Users (2019-2030)
8.3 Asia-Pacific Immune Health Product 麻豆原创 Size by Region
8.3.1 Asia-Pacific Immune Health Product Consumption Value by Region (2019-2030)
8.3.2 China Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Immune Health Product Consumption Value by Form (2019-2030)
9.2 South America Immune Health Product Consumption Value by End Users (2019-2030)
9.3 South America Immune Health Product 麻豆原创 Size by Country
9.3.1 South America Immune Health Product Consumption Value by Country (2019-2030)
9.3.2 Brazil Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Immune Health Product Consumption Value by Form (2019-2030)
10.2 Middle East & Africa Immune Health Product Consumption Value by End Users (2019-2030)
10.3 Middle East & Africa Immune Health Product 麻豆原创 Size by Country
10.3.1 Middle East & Africa Immune Health Product Consumption Value by Country (2019-2030)
10.3.2 Turkey Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Immune Health Product 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Immune Health Product 麻豆原创 Drivers
11.2 Immune Health Product 麻豆原创 Restraints
11.3 Immune Health Product Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Immune Health Product Industry Chain
12.2 Immune Health Product Upstream Analysis
12.3 Immune Health Product Midstream Analysis
12.4 Immune Health Product Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestl茅 SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
狈补迟耻谤别鈥檚
Real Nutriceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.